Clinical Investigations
Clinical study of deep learning reconstruction to improve the quality of rapidly acquired PET images
Hu Linjun, Hu Yiyi, Guo Binwei, Liang Meng, Hao Xinzhong, Qin Zhixing, Li Sijin, Wu Zhifang
Published 2021-10-25
Cite as Chin J Nucl Med Mol Imaging, 2021, 41(10): 602-606. DOI: 10.3760/cma.j.cn321828-20210514-00164
Abstract
ObjectiveTo improve the quality of 18F-fluorodeoxyglucose (FDG) PET images at different acquisition times through deep learning (DL) PET image reconstruction methods.
MethodsA total of 45 patients (20 males, 25 females; age (52.0±13.6) years) with malignant tumors and PET/CT scans from September 2020 to October 2020 in the Department of Nuclear Medicine of the First Hospital of Shanxi Medical University were included in this retrospective study. The short acquisition time 30 s/bed PET images from the raw list mode were selected as the input of DL model. DL image reconstruction model, based on the Unet algorithm, was trained to output imitated PET images with full dose standard acquisition time (3 min). The image quality evaluation and quantitative analysis were carried out for four groups of images: DL images, 30 s, 90 s, and 120 s images, respectively. The quality of PET images in four groups was evaluated using the five-point method. Liver background activities, lesions quantification parameters (maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), standard deviation (SD), signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR)), and first-order texture features (skewness, kurtosis, uniformity, entropy) were measured. Kappa test, χ2 test and one-way analysis of variance (least significant difference t test) were used for data analysis.
ResultsThe image quality scores between four groups were highly consistent (Kappa=0.799, P<0.001). The number of patients with scores≥3 in DL, 30 s, 90 s and 120 s groups were 6, 4, 7 and 8, respectively (χ2=125.47, P<0.001). The liver SD of DL group was significantly lower than that of 30 s group (0.26±0.07vs 0.43±0.11; F=3.58, t=-7.91, P<0.05). The liver SNR of DL group was higher than that of 30 s group (11.04±4.36vs 5.41±1.41; F=10.22, t=5.40, P<0.05). The liver SD and SNR of DL group were similar to those of 90 s group (0.39±0.16, 8.46±3.34;t values: -0.87 and 2.17, both P>0.05). In 18 tumor lesions with high uptake, SNR and CNR of DL group were significantly higher than those of 30 s group (60.21±29.26vs 38.38±16.54, 22.26±15.85 vs 15.41±9.51; F values: 13.09 and 7.05; t values: 5.20 and 4.04, both P<0.001). There were statistically significant differences among four groups in the first-order texture features (F values: 4.30-9.65, all P<0.05), but there was no significant difference between DL group and 120 s group (t values: from -1.25 to 0.15, all P>0.05).
ConclusionDL reconstruction model can improve the quality of short-frame PET images, which meets the needs of clinical diagnosis, efficacy evaluation and radiomics research.
Key words:
Deep learning; Image processing, computer-assisted; Positron-emission tomography; Deoxyglucose
Contributor Information
Hu Linjun
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Hu Yiyi
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Guo Binwei
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Liang Meng
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Hao Xinzhong
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Qin Zhixing
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Li Sijin
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China
Wu Zhifang
Department of Nuclear Medicine, the First Hospital of Shanxi Medical University
Collaborative Innovation Center of Molecular Imaging Precision Diagnosis and Treatment, Taiyuan 030001, China